Yamamoto Akira | Health Care Facilities For Aged Mino-o Life Plaza
スポンサーリンク
概要
関連著者
-
Kawaguchi Akito
Dept. Etilogy Pathophysiology National Cardiovascular Center
-
Yamamoto Akira
Health Care Facilities for the Aged, Minoh Life Plaza
-
Yamamura Taku
Department Of Etiology Research Institute Of National Cardiovascular Center:the Group Of The Researc
-
Yamamura Taku
Metabolism National Cardiovascular Center
-
Yamamura Taku
Research Institute National Cardiovascular Center
-
Harada-shiba Mariko
Department Of Bioscience National Cardiovascular Center Research Institute
-
MINATOYA Kenji
National Cardiovascular Center
-
YAMAMOTO Akira
Research Institute National Cardiovascular Center
-
YAMAMOTO Akira
National Cardiovascular Center
-
Tomoike Hitonobu
National Cardiovascular Center
著作論文
- FRS-076 A link between LDL Receptor (LDLR) Gene Mutation and Clinical Manifestations in Familial Hypercholesterolemia(FRS16,Basic Mechanisms of Lipid Disorders and Metabolic Syndrome (H),Featured Research Session (English),The 73rd Annual Scientific Meeti
- PJ-898 Predicting high risk patients of coronary artery disease in heterozygous familial hypercholesterolemia from clinical features(Lipid disorders(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-897 A Discontinuation of LDL-apheresis Deteriorates Prognosis of Heterozygous Familial Hypercholesterolemia(FH)(Lipid disorders(05)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-089 Has statin delayed the first event of coronary artery disease in heterozyhous familial hypercholesterolemia(FH)?(Lipid disorders(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- IS094 TFPI Competes With LPL on Endothelium : A Possible Mechanism of Low HDL.c in Atherosclerosis
- -0375-HYPERLIPIDEMIC VALVULOPATHY : VALVULAR DEMAGE IN FAMILIAL HYPERCHOLESTEROLEMIA
- Regression of Minimal Lumen Diameter of Japanese Patients with Coronary Artery Disease by Cholesterol-Lowering Therapy Using Pravastatin (ATHEROMA Study)
- Hypercholesterolemic Valvulopathy as an Aspect of Malignant Atherosclerosis
- IS200 Hypercholesterolemic Valvulopathy in FH
- LOW DENSITY LIPOPROTEIN (LDL) BINDING AFFINITY TO LDL RECEPTOR IN HYPERLIPOPROTEINEMIA